EMEA-000316-PIP02-11-M04

Key facts

Invented name
Entresto
Active substance
  • sacubitril
  • valsartan
Therapeutic area
Cardiovascular diseases
Decision number
P/0344/2019
PIP number
EMEA-000316-PIP02-11-M04
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of heart failure
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Ltd
Switzerland
Tel. +41 6132 41111
Fax +41 6132 48001
E-mail: paediatric.enquiries@novartis.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating